Effect of suplatast tosilate, an antiallergic selective Th2 cytokine inhibitor, on acute eosinophilic myocarditis: a case report

Heart Vessels. 2003 May;18(2):100-2. doi: 10.1007/s10380-002-0689-2.

Abstract

We encountered a 44-year-old woman with acute eosinophilic myocarditis that showed positive immunostaining for interleukin-4 in the area of marked infiltration of eosinophils into the myocardium. When prednisolone alone proved ineffective, supplementary treatment with suplatast tosilate, an antiallergic selective Th2 cytokine inhibitor, improved the patient's inflammation, reduced the level of cardiac enzymes, and allowed for a reduction in corticosteroid dosage without any adverse effects.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Adult
  • Anti-Allergic Agents / administration & dosage
  • Anti-Allergic Agents / pharmacology*
  • Anti-Inflammatory Agents / administration & dosage
  • Arylsulfonates / administration & dosage
  • Arylsulfonates / pharmacology*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Eosinophils / drug effects*
  • Female
  • Humans
  • Interleukin-4 / antagonists & inhibitors*
  • Myocarditis / blood
  • Myocarditis / drug therapy*
  • Myocarditis / immunology
  • Myocarditis / pathology
  • Prednisolone / administration & dosage
  • Sulfonium Compounds / administration & dosage
  • Sulfonium Compounds / pharmacology*
  • Th2 Cells / drug effects
  • Th2 Cells / immunology*
  • Time Factors

Substances

  • Anti-Allergic Agents
  • Anti-Inflammatory Agents
  • Arylsulfonates
  • Sulfonium Compounds
  • Interleukin-4
  • Prednisolone
  • suplatast tosilate